Perrigo Company has been named as an authorized generic partner by Ferndale Laboratories and has launched an authorized generic of Analpram HC Cream. Perrigo will also have the opportunity in the future to launch other Ferndale products as the authorized generic distributor.

Analpram HC Cream is a topical anaesthetic and corticosteroid combination and is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and had sales of approximately US$ 24 million for the 12 months period prior to generic market formation of last year, as measured by Wolters Kluwer Health.

Perrigo’s chairman and CEO Joseph C Papa concluded, “We are excited that Ferndale has chosen Perrigo as their preferred partner for authorized generics. This is another example of our focus on expanding our portfolio of prescription extended topical products. As always, Perrigo is committed to making quality healthcare more affordable for our customers and drive value for our shareholders.”

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products.